Frontiers in Pharmacology (Apr 2022)
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
Abstract
No abstracts available.Keywords
Frontiers in Pharmacology (Apr 2022)